Director, Clinical Monitoring Oversight

(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...

Lugar: San Francisco, CA | 25/12/2025 03:12:33 AM | Salario: S/. $235000 - 250000 per year | Empresa: Olema Oncology

Director, Clinical Monitoring Oversight

(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...

Lugar: Boston, MA | 25/12/2025 00:12:39 AM | Salario: S/. $235000 - 250000 per year | Empresa: Olema Oncology

General Manager

Contribute to long-term strategic planning, annual operating plans, and S&OP processes Evaluate new products, services...

Lugar: Kenilworth, NJ | 10/02/2026 20:02:01 PM | Salario: S/. $175000 - 250000 per year | Empresa: EqualAccess

Planning Manager - Advanced Visualization Solutions

Demand & S&OP Planning Lead a global demand planning team for AVS modalities, delivering detailed monthly forecasts... & budgeting processes. Drive problem solving globally. Partner with Planning COE to improve S&OP processes, standardize...

Lugar: Waukesha, WI | 04/02/2026 00:02:40 AM | Salario: S/. $160000 - 240000 per year | Empresa: GE HealthCare

Head of Commercial Finance - NJ

integration into the S&OP process and ongoing revenue and margin forecasts. Review business performance across revenue, margin...

Lugar: New Jersey | 28/01/2026 23:01:52 PM | Salario: S/. $213161 - 231001 per year | Empresa: Metagenics

Director, Analytical Development

(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...

Lugar: San Francisco, CA | 21/12/2025 01:12:02 AM | Salario: S/. $215000 - 230000 per year | Empresa: Olema Oncology

Director, Analytical Development

(OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer..., OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through...

Lugar: Boston, MA | 20/12/2025 21:12:41 PM | Salario: S/. $215000 - 230000 per year | Empresa: Olema Oncology